1. National Kidney Foundation. Am J Kidney Dis. 2002;39(2 Suppl 1):S1–266.
2. FDA. New warnings required on use of gadolinium-based contrast agents. U.S. Food and Drug Administration; 2010.
http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm225286.htm
. Accessed 29 March 2011.
3. Tramer MR, von Elm E, Loubeyre P, Hauser C. Br Med J. 2006;333(7570):675.
4. ESUR guidelines for the administration of contrast media. European Society of Urogenital Radiology; 2011.
http://www.esur.org/Contrast-media.51.0.html
. Accessed 28 March 2011.
5. Murphy SW, Barrett BJ, Parfrey PS. J Am Soc Nephrol. 2000;11(1):177–82.